| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $291.60M | $307.69M | $325.67M | $353.39M | $329.70M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $244.56M | $267.50M | $336.31M | $315.17M | $339.63M |
| R&D | – | – | – | – | – |
| SG&A | $146.70M | $152.26M | $171.55M | $173.28M | $179.87M |
| Operating Income | $47.04M | $40.18M | -$10.64M | $38.21M | -$9.93M |
| Interest Expense | – | – | $35.74M | $20.90M | $11.34M |
| Tax Expense | $6.20M | -$1.88M | $56.95M | $7.37M | $2.46M |
| Net Income | $13.43M | $7.12M | -$69.02M | $6.11M | -$15.62M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |